Neuroguidin Activators are a chemical class comprising compounds that indirectly influence Neuroguidin function by targeting various signaling pathways and cellular processes. These activators work primarily through the modulation of second messengers such as cyclic AMP (cAMP) and cyclic GMP (cGMP), which are pivotal in cellular responses to external signals. The activators include adenylate cyclase activators, phosphodiesterase inhibitors, and kinase inhibitors. For instance, Forskolin activates adenylate cyclase directly, thereby increasing cAMP levels, which can alter downstream signaling pathways affecting Neuroguidin. Phosphodiesterase inhibitors like IBMX, Rolipram, Cilostamide, Zaprinast, Sildenafil, and Tadalafil elevate cyclic nucleotide levels, leading to potential modulation of Neuroguidin through cAMP or cGMP-dependent pathways.
On the other hand, kinase inhibitors such as Apigenin, Myricetin, and Genistein impact various signaling cascades by inhibiting enzymes like PKC and PI3K, which play roles in synaptic plasticity and protein synthesis regulation, respectively. The interactions between these activators and Neuroguidin are not direct but result from a complex network of cellular signaling events that ultimately influence protein synthesis and neuronal development. As such, Neuroguidin activators encompass a diverse group of molecules that, by affecting different targets within the cell, can lead to the functional activation of Neuroguidin. This diversity implies that the impact of each activator on Neuroguidin's functional state is mediated through a unique set of intracellular processes. For example, activators that elevate cAMP levels may lead to the activation of protein kinase A (PKA), which can subsequently phosphorylate and modulate proteins that interact with or regulate Neuroguidin's function. Through the careful modulation of signaling pathways, Neuroguidin activators indirectly permit the precise control of neuronal gene expression patterns necessary for the maintenance of neuronal function and health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX non-selectively inhibits phosphodiesterases, increasing both cAMP and cGMP levels. This rise in cyclic nucleotides can affect the translation initiation complex and potentially impact Neuroguidin's role in regulating protein synthesis in neurons. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram selectively inhibits PDE4, elevating cAMP levels. Increased cAMP influences signaling pathways that can affect protein translation processes, potentially altering Neuroguidin activity in the nervous system. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide selectively inhibits PDE3, which increases cAMP levels. The rise in cAMP may indirectly affect Neuroguidin by modulating translation initiation and protein synthesis in neural tissues. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast selectively inhibits PDE5 and can also increase cAMP levels to a lesser extent. Elevated levels of cAMP or cGMP could modulate signaling pathways that indirectly affect Neuroguidin-mediated translational control. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin inhibits PKC and other kinases, affecting synaptic plasticity and potentially influencing signaling cascades that regulate activity of translation initiation factors associated with Neuroguidin. | ||||||
Myricetin | 529-44-2 | sc-203147 sc-203147A sc-203147B sc-203147C sc-203147D | 25 mg 100 mg 1 g 25 g 100 g | $97.00 $188.00 $260.00 $510.00 $1022.00 | 3 | |
Myricetin inhibits PI3K among other kinases. As PI3K is involved in protein synthesis regulation, myricetin could indirectly modulate Neuroguidin activity by influencing the protein translation landscape in neurons. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Dibutyryl-cAMP is a cell-permeable, hydrolysis-resistant cAMP analog that mimics cAMP action and activates cAMP-dependent pathways, potentially affecting Neuroguidin by modulating neuronal protein synthesis pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor affecting various signaling pathways, including those regulating neural cell growth and differentiation. It might indirectly affect Neuroguidin by altering translation initiation factor activity in the nervous system. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Tadalafil operates similarly to Sildenafil by selectively inhibiting PDE5, potentially increasing cAMP as well as cGMP levels and influencing Neuroguidin function through effects on signaling pathways that regulate protein synthesis. | ||||||